Work

Meta-analysis across Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium provides evidence for an association of serum vitamin D with pulmonary function

Year: 2018
Type: article
Abstract: The role that vitamin D plays in pulmonary function remains uncertain. Epidemiological studies reported mixed findings for serum 25-hydroxyvitamin D (25(OH)D)-pulmonary function association. We conducted the largest cross-sectional meta-analysis of the 25(OH)D-pulmonary function association to date, based on nine European ancestry (EA) cohorts (n 22 838) and five African ancestry (AA) cohorts (n 4290) in the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. Data were analysed using linear models by cohort and ancestry. Effect modification by smoking status (current/former/never) was tested. Results were combined using fixed-effects meta-analysis. Mean serum 25(OH)D was 68 (sd 29) nmol/l for EA and 49 (sd 21) nmol/l for AA. For each 1 nmol/l higher 25(OH)D, forced expiratory volume in the 1st second (FEV1) was higher by 1·1 ml in EA (95 % CI 0·9, 1·3; P<0·0001) and 1·8 ml (95 % CI 1·1, 2·5; P<0·0001) in AA (P race difference=0·06), and forced vital capacity (FVC) was higher by 1·3 ml in EA (95 % CI 1·0, 1·6; P<0·0001) and 1·5 ml (95 % CI 0·8, 2·3; P=0·0001) in AA (P race difference=0·56). Among EA, the 25(OH)D-FVC association was stronger in smokers: per 1 nmol/l higher 25(OH)D, FVC was higher by 1·7 ml (95 % CI 1·1, 2·3) for current smokers and 1·7 ml (95 % CI 1·2, 2·1) for former smokers, compared with 0·8 ml (95 % CI 0·4, 1·2) for never smokers. In summary, the 25(OH)D associations with FEV1 and FVC were positive in both ancestries. In EA, a stronger association was observed for smokers compared with never smokers, which supports the importance of vitamin D in vulnerable populations.
Language: English
Field: Medicine
Open Access status: bronze
Awards: G100949702, G1023103040, G1023702118, G1028935811, G1031917901, G1052397333, G1083745640, G109384441, G1097528416, G1118486281, G1141534940, G1146917014, G1156594538, G1200636938, G1220223050, G1236291273, G1243299691, G125972088, G1261793039, MESA, CORONARY HEART DISEASE AND STROKE, G1275337683, G1276754516, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G1294761135, G1332411685, G1373328648, Individual response to vitamin D treatment, G1401438683, G1409423729, G1438302022, DYNAMICS OF HEALTH,AGING, AND BODY COMPOSITION, G1460387277, G1462415530, G1483344193, G1490530680, G1497137905, G1508998135, G1527150935, G1560275704, G1585400806, G1605143468, CORONARY HEART DISEASE AND STROKE, G1640378483, G1686417863, G1691174148, G1696540499, G172405621, G1726490033, G1747129958, G1751314254, G1774001260, G178432677, G1802223128, G1913513890, G1922428914, G1982334678, G202194050, Genome-wide case-only study of antihypertensive drug-gene interactions, G2054089280, G2124389049, G2130630498, G2144938473, G2169623015, Rare variants and NHLBI traits in deeply phenotyped cohorts, G2194386449, G2215959655, G2232946593, G2234140876, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G22458031, G2252554751, G2262782284, G2301633697, G230712557, G232264632, G2326437104, G2334180555, G2391884931, G2404385439, MESA, G2444690877, G247538147, G250621538, G2545476352, G2585438117, G259863839, CORONARY HEART DISEASE &STROKE IN THE ELDERLY, G270907595, G2733059257, G2741792843, G2761914318, G278200998, G2800149121, G2815873878, MESA, G2837638605, G283874107, G286372155, G2868986223, G2899267414, G2904493376, G2905571579, G290884426, G291913881, SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READING, G2962705247, G297113894, G3008994282, G301743239, G3042145041, G3045517347, WGA Study to Identify Genetic Variants Associated with CV Events in CHS, G3064274663, G3072471125, G3093995152, G3106377335, G3114902838, G3137375862, HEALTH ABC--COORDINATING UNIT, Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium, G316474162, G3205625555, G3220743633, G322252321, G327109033, Vitamin D, falls, fractures and function in community-dwelling older adults, G3294437106, G3329991140, G33312777, G3395908852, G3402222819, G34347772, G343705321, G3462919067, G350785449, CHS research resources for the cardiovascular health of older adults, G3568487487, G3572394825, G3581052147, G3647016462, G3667269547, G3687594596, G3795986943, MESA, G3860090032, G3940493997, G3984593164, G3990748671, CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS, G399481048, G4031532843, G405311360, G4065540706, G4077798243, G4079570820, G4156743036, G4167445418, G4180778867, G4191938920, G4200864717, G4208240127, G4214380615, G4219624527, G4222455271, G423252844, G4246339746, G4250668888, G4274274695, TITLE: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), G4312169524, G43250720, G4341976608, G4401650913, G4429312988, G4498746773, G4512137732, G4590914202, G4622379297, G4647094700, G4653673457, G4678087642, G4688346656, G46991335, G4771937603, G4795516706, G481016485, G4835412467, G484463738, OPTION 3. 4/1/2014 - 3/31/2015. MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - READING CENTER, NHLBI, G4942589162, MESA, Hypercoagulability and Chronic Lung Disease in Older Adults, G5108002584, G5145575165, G5164707915, G5206110354, SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-ULTRASOUND, G5234713383, G5249188777, G5251985303, G5274979365, G5281659474, G5296600602, G5339631484, G537455924, G5386252567, G5439707361, G544148272, G55907201, G5605591545, G5617687969, G562502316, G5632764457, G5654179670, G5659011180, G5664663726, G567847597, G5713454673, G5755700318, G5787256936, G581554933, G581887176, G5899964417, G5909482378, CHS Events Follow-up Study, G6009312770, G6042749883, G6072625318, G6094624418, G6095866717, G611940047, G6128741887, G6130894301, G6195637971, G6226795708, G6266641191, G6296967160, G6359107525, G6372296772, G6398255701, Institute for Clinical and Translational Research, The Framingham Heart Study, MESA, G6436857277, G6493186444, G6493395989, G6514094751, G6552090923, G66341962, G670738241, G6742279884, G6743335547, G6948187022, G6956219616, G7007046788, G7047602405, G713258703, G7147025221, G7151333904, G716312657, G7176672723, G7217924807, G7247076997, G7269243931, G7321867456, G7333737664, MESA, G7373387228, G738360740, G7396393789, G7399262704, G7415749889, G7455404317, G7495086035, G7523308555, G7545451798, G764651519, G766700449, G766843672, G7712295779, G7718404950, G78770644, G7885066867, G8023750902, G805458286, G806768229, Clinical and Translational Science Award, G8092814076, G8423570502, G8492131798, G8614642789, CHS-Transition Phase -268055222, G8683204365, G8695911412, G8716920314, G8718892906, G8801704270, G88327988, G8852914737, Combined Cardiopulmonary Failure in COPD: SPIROMICS HF, G89231007, G9000001086, G9000004549, G9000004784, G9000006353, G9000017360, G9000019818, G9000025517, G9000026278, G9000026317, G9000027259, G9000031392, G9000046001, G9000063950, G9000065698, G9000069887, G9000071222, G9000097438, G9000124008, G9000124674, G9000139054, G9000140433, G9000143535, G9000155215, G9000166834, G9000177289, G9000202457, G9000234302, G9000284156, G9000318776, Diabetes Research Center (DRC), G905887895, G945304896, G991334795
OpenAlex ID: W2889916565
FWCI: 0.804
Cites: 54
Cited by: 10
Related to: 10